ICN Clinical Trials & Research Center

Introduction

Clinical trials are used to determine whether investigational new drugs or investigational treatments are both safe and effective. IC patients often choose to participate in studies because it may provide access to the latest investigational therapies and medications at no cost. Studies also allow the patient to interact with some of the best IC researchers in the country.

If you are considering participating in a trial, we suggest that you read the following resources:

Clinical Trial & Research News

The Psychological Effect of IC

Rachel Fazio MS PLPC, a licensed counselor and psychology graduate student who was also diagnosed with IC seven years ago, is conducting research about the psychological aspects of IC. As a patient, she was surprised to find that the stereotype among medical professionals that IC is "all in our heads" still exists despite evidence that IC patients have visible bladder damage. To address that stereotype, she is doing a study to look at the psychological profiles of IC patients. She's using the Minnesota Multiphasic Personality Inventory 2, which is sort of a gold standard of psychological testing. It's a simple paper and pencil test though, in this study, it will be conducted via a phone interview.

If you are interested in participating, and we hope you do, please contact Rachel at:

Phone: 417-763-4043

E-mail: rfazio@Forest.edu

NIH Launches Effort To Advance Study of Urologic Chronic Pelvic Pain Disorders

(September 2008) The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.

The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network includes six Discovery Sites that will conduct the studies and two Core Sites that will coordinate data collection, analyze tissue samples, and provide technical support. The Discovery Sites are at: Northwestern University, Chicago; the University of California, Los Angeles; the University of Iowa, Iowa City; the University of Michigan, Ann Arbor; the University of Washington, Seattle; and Washington University, St. Louis. Core Sites are at the University of Colorado, Denver and the University of Pennsylvania, Philadelphia.

The MAPP initiative is unusual in requiring investigators to conduct highly collaborative research of the most common urologic chronic pelvic pain syndromes from a broadened systemic perspective. This is a major shift from earlier organ-specific research on the two most prominent urologic chronic pelvic pain disorders, interstitial cystitis/painful bladder syndrome, and chronic prostatitis/chronic pelvic pain syndrome.

Read the official NIDDK announcement

Current Clinical Trials Listings

There are a few services on the web that provide listings of current trials. Clinicaltrials.gov, our favorite, is a service sponsored by the National Institutes of Health. Centerwatch.com is an industry sponsored listing service.

Current NIDDK IC/PBS Research Centers

IC research is done at a wide variety of urology clinics. Many local and regional clinics participate in pharmaceutical company sponsored studies and/or may conduct their own research. Universities are the foundation for IC research not only for their access to excellent researchers but also large populations of patients who might participate. IC research centers which are funded by the National Institutes of Health (NIDDK) are often considered the best in the country.

Currently, there are two research networks, the ICCRN (IC research centers) and the CPCRN (prostatitis research centers) that are united under a single umbrella organization, the UPPCRN (Urologic Pelvic Pain Collaborative Research Network) and, in 2008, the MAPP research network was introduced. The clinics and investigators below are current participates.

CALIFORNIA

Stanford University Medical Center (ICCRN) - Christopher Payne, M.D. & Rodney Anderson, M.D. Contact: Debra Clay, R.N. - Research Coordinator at (650) 724-1753

David Geffen School of Medicine at UCLA (CPCRN) - Mark S. Litwin, M.D., Scott Zeitlin, M.D., Nand S. Datta, M.D. Contact: Gwendolyn Byrd, MA, at (310) 267-2526

King-Drew Medical Center, Urology/Dept. of Surgery (CPCRN) - Dr. Nand Datta Contact: Kawajalen Mervin at 310-668-4545

UCLA (MAPP) - Emeran Mayer MD, Larissa Rodriguez MD. Project Director: Bruce Naliboff, PhD

COLORADO

Univ. of Colorado - Denver (MAPP) - Technology and Tissue Center - M. Scott Lucia MD

ILLINOIS

Loyola University Medical Center (ICCRN) - Marypat Fitzgerald, M.D. & Linda Brubaker, M.D. Contact: Judith Senka, R.N. - Research Coordinator at (708) 216-8495

Northwestern University Feinberg School of Medicine (CPCRN) - Anthony J. Schaefer, M.D., Robert B. Nadler, M.D., J. Quentin Clemens, M.D. Contact: Darlene Marko RN, BSN, CCRC(312) 695-3898

Northwestern University Feinberg School of Medicine (MAPP) - David Klumpp, PhD, Anthony J. Schaefer, M.D.  Project Director: Elizabeth Calhoun, PhD

IOWA

University of Iowa Hospitals (ICCRN) - Karl Kreder, M.D. , Michael O’Donnell, M.D. Contact: Mary Eno, R.N. - Research Coordinator at (319) 384-9265 Kelley O’Berry - Recruitment Coordinator at (319) 384-5064

University of Iowa Hospitals (MAPP) - Karl Kreder M.D., Project Directors: Catherine Bradley MD, Yi Luo PhD, Susan Lutgendorf PhD, Michael O'Donnell MD, Satish Rao PhD.

MARYLAND

University of Maryland (ICCRN) - Toby Chai, M.D., Susan Keay, M.D. Contact: Judith Murray, CCRC - Research Coordinator (410) 328-5784

MICHIGAN - Detroit

Henry Ford Hospital (ICCRN) - David Burks, M.D. Contact: Jill Sullivan, R.N., B.S.N. - Research Coordinator at (313) 916-3140 Michelle Peabody, R.N. - Research Coordinator at (313) 916-8265

William Beaumont Hospital (ICCRN) - Kenneth Peters, M.D. Contact: Eleanor Anton, R.N. - Research Coordinator at (248) 551-0885

University of Michigan, Ann Arbor (MAPP) - Daniel Clauw  MD, J. Quentin Clemens MD

MISSISSIPPI

The University of Mississippi Medical Center (CPCRN) - Paige White, M.D. Contact: (610) 984-5195

MISSOURI

Washington Univ - St. Louis (MAPP) - Gerald Andriole MD, Chief Division of Urology. Project Directors: Thomas Hooton MD, Graham Colditz MD, Robert Gereau PhD, Timothy Ness MD and Barry Kong PhD.

NEW YORK

University of Rochester Medical Center (ICCRN) - Robert Mayer, M.D. & Edward M. Messing, M.D. Contact: Elizabeth Smith, B.S. - Research Coordinator at (585) 275-0989 Kay Rust, R.N., M.S.N., F.N.P - Research Coordinator at (585) 275-0133

OHIO

Cleveland Clinic (CPCRN) - Daniel Shoskes, M.D., Contact: Donel Murphy (216) 445-7505

PENNSYLVANIA

Univ. of Pennsylvania (ICCRN)- Philip Hanno, M.D. Diane Newman, R.N.C., M.S.N., CRNP Contact: Lilliam Ribeiro, B.S. - Research Coordinator at (215) 615-3780

Univ. Of Pennsylvania (MAPP) - Datacoordinating Center 0 J. Richard Landis MD

Temple University School of Medicine (CPCRN) - Michel A. Pontari, M.D., Contact: Melody Santiago, RN, (215) 707-3783

WASHINGTON

Univ. of Washington (ICCRN) - Richard E. Berger, M.D., Jane Miller, M.D. & Elizabeth A. Miller, M.D. Contact: Sharon Downing, R.N. - Research Coordinator at (206) 598-0850

Univ. of Washington (CPCRN) - John N. Krieger, M.D., P.I., Robert Sweet, M.D., Co-PI & Susan O. Ross, R.N. Contact: Leslie Butler 206-616-7416

Univ. of Washington (MAPP) - Dedra Buchwald MD. Project Directors: Niloofar Afari PhD, John Krieger MD, Alvin Liu PhD

CANADA

Queen's University Kingston, Ontario, Canada (ICCRN) - J. Curtis Nickel, M.D., Contact: Joe Downey, M.Sc., CCRP, (613) 533-2894

MALAYSIA

University of Sciences Malaysia (CPCRN) - Liong Men Long, M.D., Contact: Shaun Lee Wen Huey, Research Coordinator, nuahsell@yahoo.com, Mobile: 012-2030508

ICN Founder Jill OsborneA note from ICN Founder Jill Osborne - The best gift that an IC patient can give is the opportunity to learn more about this unique and misunderstood condition by participating in research studies and clinical trials. Whether it's quick phone survey, the donation of blood or urine samples or trying new therapies, the IC research movement depends upon patients like you who can see value in participating. It's a whole new mind set. Instead of saying "Why me?", the IC patient who participates is saying "Why not me? I can be a part of the cure." Wouldn't that be something?